Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Degree

Medical Specialty

Submit

Leveraging Metabolic-Driven Treatment Strategies to Target the Origins of NASH

Source: Leveraging Metabolic-Driven Treatment Strategies to Target the Origins of NASH

Experts provide a review of therapeutic interventions for NAFLD/NASH, including key recommendations from the latest clinical care guidelines and the safety and efficacy of emerging agents.

Manal F. Abdelmalek, MD, MPH
Program Director

Rohit Loomba, MD, MHSc

Brent Tetri, MD

Released: December 7, 2022 Expiration: No longer available for credit

Welcome to the CCO Site

Leveraging Metabolic-Driven Treatment Strategies to Target the Origins of NASH

Leaving the CCO site